Cargando…

Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa

BACKGROUND: Currently, there is no treatment for retinal degenerative diseases (RDD) such as retinitis pigmentosa (RP). Stem cell-based therapies could provide promising opportunities to repair the damaged retina and restore vision. Thus far, primarily adult mesenchymal stem cells (MSCs) have been i...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Christina, Agosta, Patrina, McKee, Christina, Walker, Keegan, Mazzella, Matteo, Alamri, Ali, Svinarich, David, Chaudhry, G. Rasul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994263/
https://www.ncbi.nlm.nih.gov/pubmed/35395806
http://dx.doi.org/10.1186/s13287-022-02828-w
_version_ 1784684071347027968
author Brown, Christina
Agosta, Patrina
McKee, Christina
Walker, Keegan
Mazzella, Matteo
Alamri, Ali
Svinarich, David
Chaudhry, G. Rasul
author_facet Brown, Christina
Agosta, Patrina
McKee, Christina
Walker, Keegan
Mazzella, Matteo
Alamri, Ali
Svinarich, David
Chaudhry, G. Rasul
author_sort Brown, Christina
collection PubMed
description BACKGROUND: Currently, there is no treatment for retinal degenerative diseases (RDD) such as retinitis pigmentosa (RP). Stem cell-based therapies could provide promising opportunities to repair the damaged retina and restore vision. Thus far, primarily adult mesenchymal stem cells (MSCs) have been investigated in preclinical and clinical studies, and the results have not been convincing. We applied a new approach in which primitive (p) MSC-derived retinal progenitor cells (RPCs) were examined to treat retinal degeneration in an rd12 mouse model of RP. METHODS: Well-characterized pMSCs and RPCs labeled with PKH26 were intravitreally injected into rd12 mice. The vision and retinal function of transplanted animals were analyzed using electroretinography. Animals were killed 4 and 8 weeks after cell transplantation for histological, immunological, molecular, and transcriptomic analyses of the retina. RESULTS: Transplanted RPCs significantly improved vision and retinal thickness as well as function in rd12 mice. pMSCs and RPCs homed to distinct retinal layers. pMSCs homed to the retinal pigment epithelium, and RPCs migrated to the neural layers of the retina, where they improved the thickness of the respective layers and expressed cell-specific markers. RPCs induced anti-inflammatory and neuroprotective responses as well as upregulated the expression of genes involved in neurogenesis. The transcriptomic analysis showed that RPCs promoted neurogenesis and functional recovery of the retina through inhibition of BMP and activation of JAK/STAT and MAPK signaling pathways. CONCLUSIONS: Our study demonstrated that RPCs countered inflammation, provided retinal protection, and promoted neurogenesis resulting in improved retinal structure and physiological function in rd12 mice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02828-w.
format Online
Article
Text
id pubmed-8994263
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89942632022-04-10 Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa Brown, Christina Agosta, Patrina McKee, Christina Walker, Keegan Mazzella, Matteo Alamri, Ali Svinarich, David Chaudhry, G. Rasul Stem Cell Res Ther Research BACKGROUND: Currently, there is no treatment for retinal degenerative diseases (RDD) such as retinitis pigmentosa (RP). Stem cell-based therapies could provide promising opportunities to repair the damaged retina and restore vision. Thus far, primarily adult mesenchymal stem cells (MSCs) have been investigated in preclinical and clinical studies, and the results have not been convincing. We applied a new approach in which primitive (p) MSC-derived retinal progenitor cells (RPCs) were examined to treat retinal degeneration in an rd12 mouse model of RP. METHODS: Well-characterized pMSCs and RPCs labeled with PKH26 were intravitreally injected into rd12 mice. The vision and retinal function of transplanted animals were analyzed using electroretinography. Animals were killed 4 and 8 weeks after cell transplantation for histological, immunological, molecular, and transcriptomic analyses of the retina. RESULTS: Transplanted RPCs significantly improved vision and retinal thickness as well as function in rd12 mice. pMSCs and RPCs homed to distinct retinal layers. pMSCs homed to the retinal pigment epithelium, and RPCs migrated to the neural layers of the retina, where they improved the thickness of the respective layers and expressed cell-specific markers. RPCs induced anti-inflammatory and neuroprotective responses as well as upregulated the expression of genes involved in neurogenesis. The transcriptomic analysis showed that RPCs promoted neurogenesis and functional recovery of the retina through inhibition of BMP and activation of JAK/STAT and MAPK signaling pathways. CONCLUSIONS: Our study demonstrated that RPCs countered inflammation, provided retinal protection, and promoted neurogenesis resulting in improved retinal structure and physiological function in rd12 mice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02828-w. BioMed Central 2022-04-08 /pmc/articles/PMC8994263/ /pubmed/35395806 http://dx.doi.org/10.1186/s13287-022-02828-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Brown, Christina
Agosta, Patrina
McKee, Christina
Walker, Keegan
Mazzella, Matteo
Alamri, Ali
Svinarich, David
Chaudhry, G. Rasul
Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa
title Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa
title_full Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa
title_fullStr Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa
title_full_unstemmed Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa
title_short Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa
title_sort human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994263/
https://www.ncbi.nlm.nih.gov/pubmed/35395806
http://dx.doi.org/10.1186/s13287-022-02828-w
work_keys_str_mv AT brownchristina humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa
AT agostapatrina humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa
AT mckeechristina humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa
AT walkerkeegan humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa
AT mazzellamatteo humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa
AT alamriali humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa
AT svinarichdavid humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa
AT chaudhrygrasul humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa